Navi Mumbai
08045132072
+918209542042

ROXARIVABEN 2.5

Cardiology range by rivaroxaban 2.5 mg

ROXARIVABEN 2.5

INR 82 INR 117
In stockcod available
Phone Number

Email Address boost@sterispharma.com

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Navi Mumbai, Maharashtra, India

Navi Mumbai, India, 0

Description

ROXARIVABEN 2.5 is a clinically proven oral anticoagulant formulation containing Rivaroxaban 2.5 mg, developed to help prevent life-threatening blood clots. It belongs to a class of medications known as direct oral anticoagulants (DOACs), and specifically works as a Factor Xa inhibitor. ROXARIVABEN 2.5 is widely used in medical settings for patients at risk of developing thromboembolic events due to various cardiovascular or surgical conditions. Rivaroxaban is used to treat and prevent deep venous thrombosis (DVT), pulmonary embolism (PE), and other complications related to abnormal clot formation. What is ROXARIVABEN 2.5? ROXARIVABEN 2.5 is a prescription medicine containing Rivaroxaban 2.5 mg, which belongs to the anticoagulant class of drugs. It helps in reducing the formation of harmful clots by inhibiting Factor Xa, a crucial protein involved in the blood clotting process. This targeted mechanism allows for effective clot prevention with a lower risk of severe bleeding than traditional anticoagulants. Rivaroxaban 2.5mg Tablet is a medicine known as an anticoagulant or blood thinner. It helps prevent and treat blood clots. Uses of ROXARIVABEN 2.5: ROXARIVABEN 2.5 is used for several indications, including: Prevention of atherothrombotic events in patients with coronary artery disease (CAD) or peripheral artery disease (PAD). Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (when used in combination with aspirin or other medications as directed). Prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). Used after certain orthopedic surgeries (such as hip or knee replacement) to prevent clot formation. In combination therapy for acute coronary syndrome (ACS) when advised by the physician. Side Effects of ROXARIVABEN 2.5: As with any anticoagulant, the most common side effect of ROXARIVABEN 2.5 is bleeding. This may include nosebleeds, gum bleeding, heavy periods, or bruising easily. Other side effects may include: Gastrointestinal discomfort (nausea, stomach pain, indigestion) Dizziness or fatigue Headache Anemia Rare but serious side effects include internal bleeding or bleeding in the brain, which requires immediate medical attention. Precautions Before Using ROXARIVABEN 2.5: Inform your doctor if you have a history of bleeding disorders, liver disease, kidney impairment, or recent surgery. Avoid using this medicine if you have active bleeding or are at high risk of uncontrolled bleeding. Not recommended during pregnancy or breastfeeding unless absolutely necessary. Avoid alcohol and NSAIDs (like ibuprofen) as they may increase bleeding risk. Notify your doctor if you experience symptoms like unusual bruising, prolonged bleeding, black stools, or blood in urine. Drug Interactions – What drugs interact with ROXARIVABEN 2.5? ROXARIVABEN 2.5 may interact with several medications that either increase or decrease its anticoagulant effects: Antiplatelet drugs (e.g., aspirin, clopidogrel) may increase bleeding risk. Other anticoagulants (e.g., warfarin, heparin) should not be used concurrently unless prescribed specifically. NSAIDs (e.g., ibuprofen, naproxen) can increase gastrointestinal bleeding risk. Antifungal medications (e.g., ketoconazole) and certain antibiotics (e.g., erythromycin, rifampin) can affect drug metabolism. HIV protease inhibitors, seizure medications (e.g., phenytoin, carbamazepine), and St. John's Wort may reduce effectiveness. Conclusion: ROXARIVABEN 2.5 (Rivaroxaban 2.5 mg) is a modern, effective, and well-tolerated oral anticoagulant that plays a vital role in preventing and managing blood clots. It helps safeguard patients against serious complications like stroke, pulmonary embolism, and DVT, especially those with underlying cardiovascular conditions. However, as with all blood thinners, it should be used with care, under the supervision of a healthcare provider, and with full awareness of potential interactions and bleeding risks.

Other Medicines

view all